Qiagen (QGEN)
37.56
+1.11 (3.05%)
Upcoming Events
Latest Headlines
Form SD QIAGEN N.V.
June 1, 2026 6:01 AM - SEC Filing
QIAGEN releases digital PCR assays for Bundibugyo ebolavirus research
May 28, 2026 4:06 PM - StreetInsider
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak
May 28, 2026 4:05 PM - BizWire
QIAGEN launches AI assistant for laboratory workflow support
May 20, 2026 4:07 PM - StreetInsider
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
May 20, 2026 4:05 PM - BizWire
QIAGEN partners with NVIDIA to integrate AI into drug discovery platform
May 19, 2026 4:05 PM - StreetInsider
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
May 19, 2026 4:05 PM - BizWire
Qiagen NV (QGEN) PT Lowered to $36 at Stifel on 'Lower Growth Outlook'
May 18, 2026 7:40 AM - StreetInsider
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
May 12, 2026 2:00 AM - BizWire
Form 6-K QIAGEN N.V. For: Mar 31
May 8, 2026 6:06 AM - SEC Filing
Form 6-K QIAGEN N.V. For: Mar 31
May 8, 2026 6:06 AM - SEC Filing
Qiagen NV (QGEN) PT Lowered to $40 at TD Cowen
May 7, 2026 8:53 AM - StreetInsider
QIAGEN plans automated tuberculosis testing workflow for late 2027
May 7, 2026 6:01 AM - StreetInsider
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
May 7, 2026 6:00 AM - BizWire
Qiagen (QGEN) Reports In-Line Q1 EPS
May 7, 2026 1:58 AM - StreetInsider
QIAGEN Reports Full Results for Q1 2026
May 6, 2026 4:05 PM - BizWire
Form 6-K QIAGEN N.V. For: Mar 31
May 1, 2026 9:49 AM - SEC Filing
Qiagen NV (QGEN) PT Lowered to $45 at JPMorgan
April 29, 2026 9:01 AM - StreetInsider
QIAGEN NV (QIA:GR) (QGEN) PT Lowered to EUR34 at Morgan Stanley
April 29, 2026 4:31 AM - StreetInsider
Baird Upgrades Qiagen NV (QGEN) to Outperform
April 29, 2026 2:45 AM - StreetInsider
Qiagen NV (QGEN) PT Lowered to $38 at Barclays
April 28, 2026 4:07 PM - StreetInsider
QIAGEN lowers 2026 outlook as QuantiFERON immigration testing drops
April 27, 2026 4:16 PM - StreetInsider
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
April 27, 2026 4:16 PM - BizWire
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
April 16, 2026 4:05 PM - BizWire
QIAGEN launches bloodstream infection testing panel
April 14, 2026 4:05 PM - StreetInsider
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
April 14, 2026 4:05 PM - BizWire
Barclays Downgrades Qiagen NV (QGEN) to Equalweight
April 14, 2026 6:35 AM - StreetInsider
QIAGEN NV (QIA:GR) (QGEN) PT Raised to EUR44 at Morgan Stanley
April 14, 2026 5:01 AM - StreetInsider
Qiagen NV (QGEN) PT Lowered to $46 at TD Cowen
April 13, 2026 8:41 AM - StreetInsider
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
March 20, 2026 7:30 AM - BizWire
Form 20-F QIAGEN N.V. For: Dec 31
March 20, 2026 6:06 AM - SEC Filing
Form IRANNOTICE QIAGEN N.V.
March 20, 2026 6:05 AM - SEC Filing
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
March 19, 2026 4:05 PM - BizWire
Deutsche Bank Upgrades Qiagen NV (QGEN) to Buy
March 13, 2026 4:15 AM - StreetInsider
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
March 10, 2026 5:05 PM - BizWire
Qiagen (QGEN) call put ratio 2.8 calls to 1 put with a focus on April 45 and 50 calls
March 10, 2026 3:11 PM - StreetInsider
Full Article List
